SBMFF (Sino Biopharmaceutical) Total Debt per Share: $0.13 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SBMFF Sino Biopharmaceutical Ltd SBMFF
61 GF Score
Price $0.75
GF Value $0.65
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Sino Biopharmaceutical Total Debt per Share?

Sino Biopharmaceutical SBMFF +15.29% 61 Total Debt per Share is $0.13 as of Dec. 2025. GuruFocus rates SBMFF with a GF Score™ of 61/100 and a GF Value™ of $0.65 (Modestly Overvalued). The stock has 3 warning signs investors should review.

$0.13 (As of Dec. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Sino Biopharmaceutical's Total Debt Per Share for the quarter that ended in Dec. 2025 was $0.13.

Sino Biopharmaceutical Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Sino Biopharmaceutical's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sino Biopharmaceutical Total Debt per Share Chart

Sino Biopharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.11 0.10 0.07 0.13

Sino Biopharmaceutical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 0.09 0.13 0.14
SBMFF
61GF Score
Sino Biopharmaceutical Ltd SBMFF
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sino Biopharmaceutical Total Debt per Share Calculation

Sino Biopharmaceutical's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(1,086+1,195)/17,892
=0.13

Sino Biopharmaceutical's Total Debt Per Share for the quarter that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(1,086+1,195)/17,892
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $0.13 mean?
Sino Biopharmaceutical (SBMFF) has a Total Debt per Share of $0.13 as of Dec. 2025. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Sino Biopharmaceutical and its competitors.
Is Sino Biopharmaceutical's Total Debt per Share too high?
Sino Biopharmaceutical's current Total Debt per Share is $0.13. Overall, Sino Biopharmaceutical has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sino Biopharmaceutical's Total Debt per Share compare to VRTX and REGN?
Sino Biopharmaceutical's Total Debt per Share of $0.13 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Sino Biopharmaceutical and its competitors. Sino Biopharmaceutical's current Total Debt per Share is $0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Biopharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Sino Biopharmaceutical (SBMFF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.65, compared to a current price of $0.75 — trading 15.4% above its estimated fair value. The current Total Debt per Share is $0.13. Sino Biopharmaceutical's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Sino Biopharmaceutical (SBMFF), the current Total Debt per Share is $0.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sino Biopharmaceutical (SBMFF) Overvalued in 2026?

Based on GuruFocus' analysis, Sino Biopharmaceutical stock appears to be overvalued. The current stock price of $0.75 is trading 15.4% above its estimated GF Value™ of $0.65. GuruFocus considers Sino Biopharmaceutical to be Modestly Overvalued.

Key valuation signals for SBMFF:

  • Total Debt per Share: $0.13
  • GF Value™: $0.65 vs. price of $0.75 (15.4% above fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the SBMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sino Biopharmaceutical Business Description

Address 1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Sino Biopharmaceutical Ltd is an investment holding company. The company and its subsidiaries are principally engaged in the research and development, production and sale of a series of pharmaceutical products. Its business covering the entire industrial chain of R&D, production and commercialization of drugs, biological products and high-end generic drugs. The company's therapeutic areas include: oncology, liver disease, respiratory, and surgery/pain relief. The company's revenue was generated from the sale of pharmaceutical products in the Chinese mainland.
61GF Score

Get the complete analysis for SBMFF

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75
Price
$0.65
GF Value